Drug Trial News

RSS

Two recent studies are souring milk's image among health authorities

Two recent studies are souring milk's image among health authorities. One, published in the November issue of the American Journal of Clinical Nutrition, shows that women who consume two or more glasses of milk a day have twice the risk of a certain form of ovarian cancer than those who rarely or never consume milk.

6 Dec 2004

Study shows internet use can lead to fitness

People using the Internet as a guide to getting active were just as successful as those using face-to-face briefings.

6 Dec 2004

TV sporting advert breaks expose children to violent and unsafe behavior

Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.

6 Dec 2004

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Results from a clinical trial presented at the American Society of Hematology 46th Annual Meeting and Exposition (ASH) demonstrated that Zevalin (ibritumomab tiuxetan), administered as a first-line therapy, induced a 100 percent response rate in a small population of patients with low-grate follicular lymphoma (FL).

6 Dec 2004

Study shows long-term benefits for chronic myeloid leukemia patients receiving therapy with imatinib

CHU in Poitiers, France, yesterday announced results of a study showing that newly diagnosed patients with a certain form of leukemia who are treated early with imatinib are more likely to achieve complete cytogenetic responses (the elimination of leukemic cells, a major goal of therapy) and have improved long-term outcomes.

6 Dec 2004

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Genetic target found for pediatric leukemia

A molecular target newly discovered by scientists at two prestigious research institutes may pave the way for new treatments that could combat an aggressive form of leukemia, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Bcl-6 oncogene - genetic target for lymphoma treatment

Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene -- that is, one with the potential to cause a normal cell to become cancerous -- but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

A new treatment for patients with chronic myeloid leukemia

A new treatment for patients with chronic myeloid leukemia (CML) -- a disorder marked by an overproduction of white blood cells -- yields positive results in those who have relapsed on imatinib, the standard treatment for the disease, according to a Phase I study to be presented today at the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genta Incorporated announced that two new studies have shown that Genasense (oblimersen sodium) Injection, the Company's lead anticancer drug, showed synergistic activity with both bortezomib (Velcade; Millennium Pharmaceuticals, Inc.) and rituximab (Rituxan; Genentech, Idec) in experimental models of B-cell non-Hodgkin's lymphoma (NHL).

5 Dec 2004

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

At the 46th Annual Meeting of the American Society of Hematology (ASH) preliminary data were presented from a phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia (MDS).

5 Dec 2004

Single dose phase I data on CG53135 for the prevention of oral mucositis

CuraGen Corporation has announced results presented from a Phase I clinical trial with CG53135 for the prevention of oral mucositis (OM) in patients receiving high dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (AHSCT) at the ASH 46th Annual Meeting in San Diego, CA.

5 Dec 2004

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML)

4 Dec 2004

Botox may reduce the incidence of keloids, improving the appearance of scars

Can a modern-day drug cure an age-old healing disorder that causes more harm than the actual injury?

4 Dec 2004

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Genta Incorporated announced that results from the Company's randomized Phase 3 clinical trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory multiple myeloma were presented today at the annual meeting of the American Society of Hematology (ASH) in San Diego, CA.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004

Study shows gender differences with tatoos and piercing among college students

For college students anxious to rebel against their parents’ fashion sensibilities, getting a tattoo or piercing may be the modern-day equivalent of the 1960s-era fascination with long hair and love beads.

4 Dec 2004

Study will help cancer survivors treated with radical hysterectomy regain their sexual health

When Linda Mercer underwent a radical hysterectomy to treat her cancer, she found herself and her husband struggling to regain a satisfying sex life.

4 Dec 2004

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

Children who suffer from behavioral and learning problems after their central nervous systems have been exposed to chemotherapy or radiation appear to benefit from treatment with methylphenidate (MPH), the drug commonly known by the brand name Ritalin®.

4 Dec 2004

One-fifth of people in Southwestern Pennsylvania—nearly half a million people—report having a disability

“The size of the population with disabilities is rather surprising,” said Ralph Bangs, codirector of the Urban and Regional Research Program in Pitt’s Center for Social and Urban Research (UCSUR), who coauthored the study with José René Argueta, a Pitt Ph.D. candidate in political science.

4 Dec 2004

Drug Trial News

Two recent studies are souring milk's image among health authorities

Study shows internet use can lead to fitness

TV sporting advert breaks expose children to violent and unsafe behavior

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Study shows long-term benefits for chronic myeloid leukemia patients receiving therapy with imatinib

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

Genetic target found for pediatric leukemia

Bcl-6 oncogene - genetic target for lymphoma treatment

A new treatment for patients with chronic myeloid leukemia

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Single dose phase I data on CG53135 for the prevention of oral mucositis

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

Botox may reduce the incidence of keloids, improving the appearance of scars

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Study focused on patients with chemotherapy-related anemia

Study shows gender differences with tatoos and piercing among college students

Study will help cancer survivors treated with radical hysterectomy regain their sexual health

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

One-fifth of people in Southwestern Pennsylvania—nearly half a million people—report having a disability

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News